Antithymocyte Globulin: Clinical Trials

71 trials of Antithymocyte Globulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

45 completed, 13 terminated, 4 unknown, 4 withdrawn. 51 Phase 2, 14 Phase 1, 8 Phase 3, 4 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 251Completed 29, Terminated 11, Withdrawn 4, Unknown 3, Active not recruiting 2, Recruiting 2
Phase 114Completed 10, Terminated 2, Active not recruiting 1, Recruiting 1
Phase 38Completed 6, Terminated 1, Unknown 1
Not applicable4Completed 3, Terminated 1
Phase 42Completed 2
Early Phase 11Terminated 1

Follow Antithymocyte Globulin: new trials by email Literature Review of Antithymocyte Globulin trials Research Report on Antithymocyte Globulin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
Anti-Thymocyte Globulin, Biospecimen Collection, Bone Marrow Aspirate - Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia
Phase 1RecruitingCity of Hope Medical Center62024-11-152026-01-05
A Study of TCD601 in de Novo Renal Transplant Recipients
TCD601, belatacept, ATG - Renal Transplantation
Phase 2CompletedITB-Med LLC762023-12-282026-05-05
STOP-T1D Low-Dose (ATG)
Antithymocyte Globulin, Placebo (for ATG) - Diabetes Mellitus, Type 1
Phase 2TerminatedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)22023-11-012026-05-07
Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy
Romiplostim, Antithymocyte Globulin, Cyclosporine A - Severe Aplastic Anemia (SAA)
Phase 2WithdrawnAmgen2023-08-312023-09-29
Selective CD28 Blockade in Renal Transplant Recipients
Lulizumab, Tacrolimus, Thymoglobulin® - Kidney Transplantation, Renal Transplant Recipients
Phase 2WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2022-01-102023-03-22
Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
Individual Antithymocyte globulin, Antithymocyte globulin - Haploidentical Hematopoietic Stem Cell Transplantation
Phase 3CompletedChinese PLA General Hospital2042022-01-012026-01-21
Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Anti-Thymocyte Globulin, Busulfan, Cyclophosphamide - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 2WithdrawnFred Hutchinson Cancer Center2021-06-012021-06-30
Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
Antithymocyte Globulin - Haploidentical Hematopoietic Stem Cell Transplantation
Phase 2UnknownChinese PLA General Hospital632020-12-012023-04-11
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
Anti-Thymocyte Globulin, Cyclophosphamide, Cytokine-treated Veto Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center162019-08-082026-06-11
RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT
Cytarabine - Acute Leukemia, Myelodysplastic Syndromes
Phase 2UnknownPeking University People's Hospital502018-02-012024-03-26
RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
Cytarabine - Myelodysplastic Syndromes
Phase 2UnknownPeking University People's Hospital502018-02-012022-04-20
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
Anti-Thymocyte Globulin, Busulfan, Clofarabine - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2CompletedM.D. Anderson Cancer Center62017-10-132023-10-11
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin - Kidney Transplant, Type 1 Diabetes
Phase 2CompletedMassachusetts General Hospital22017-01-012023-12-22
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
Thymoglobulin, Bortezomib, Tacrolimus - Acute Leukemia, Chronic Lymphocytic Leukemia
Phase 2TerminatedEmory University52016-09-012018-04-30
Personalized NK Cell Therapy in CBT
Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2RecruitingM.D. Anderson Cancer Center1002016-05-192026-11-02
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
living related donor partial liver transplantation, Total body irradiation, Bone marrow transplant from same donor - Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant)
Phase 2WithdrawnSidney Kimmel Comprehensive Cancer Center at Johns Hopkins2016-03-012018-06-15
Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy
HSCT from MSD, HSCT from MUD, HSCT from HRD - Acute Leukemia, Chronic Myeloid Leukemia
Not applicableCompletedNanfang Hospital, Southern Medical University8762015-06-012020-03-05
CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
Anti-Thymocyte Globulin, Cyclosporine, Mycophenolate Mofetil - Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma
Phase 2CompletedRobert Lowsky182015-06-012021-06-24
Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant
Allogeneic Bone Marrow Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Anti-Thymocyte Globulin - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission
Phase 1CompletedM.D. Anderson Cancer Center702014-03-062022-01-06
Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients
sirolimus, tacrolimus, mycophenolate - Disorder Related to Renal Transplantation, Cytomegalovirus Infections
Phase 4CompletedAssociação Médico Espírita de Botucatu482014-01-012016-02-17

Showing 20 of 71. Sign in to see all of them.

Conditions studied

Myelodysplastic Syndromes (25)  ·  Leukemia, Myeloid, Acute (16)  ·  Hodgkin Disease (11)  ·  Leukemia (11)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (11)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (10)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (10)  ·  Lymphoma, Non-Hodgkin (9)  ·  Anemia, Aplastic (8)  ·  Diabetes Mellitus, Type 1 (8)  ·  Graft vs Host Disease (7)  ·  Hematologic Neoplasms (7)  ·  Lymphoma (7)  ·  Anemia, Refractory, with Excess of Blasts (4)  ·  Hypoglycemia (4)

Sponsors

M.D. Anderson Cancer Center (28)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (8)  ·  Fred Hutchinson Cancer Center (4)  ·  Masonic Cancer Center, University of Minnesota (4)  ·  Chinese PLA General Hospital (2)  ·  Massachusetts General Hospital (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Peking University People's Hospital (2)  ·  Amgen (1)  ·  Associação Médico Espírita de Botucatu (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Children's Oncology Group (1)  ·  City of Hope Medical Center (1)  ·  Emory University (1)  ·  Fate Therapeutics (1)

Countries

United States (62)  ·  China (5)  ·  Canada (3)  ·  Australia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Andrew Posselt, MD, PhD (2)  ·  Bernhard Hering, MD (2)  ·  Camillo Ricordi, MD (2)  ·  Chitra M. Hosing, MD (2)  ·  Elizabeth Shpall, MD (2)  ·  Issa Khouri (2)  ·  Leona Holmberg (2)  ·  Paolo Anderlini, MD (2)  ·  Richard E. Champlin, MD (2)  ·  Xiao-Jun Huang (2)  ·  Xunrong Luo, MD, PhD (2)  ·  Ali Naji, MD, PhD (1)  ·  Ali Naji, PhD (1)  ·  Amanda Olson (1)  ·  Amin Alousi, MD (1)

Results publications

PMID 20107229, PMID 20383216, PMID 20946966, PMID 23234514, PMID 23438305, PMID 23630300, PMID 23901089, PMID 23996087, PMID 24622416, PMID 25145344, PMID 25629445, PMID 25778529, PMID 26416896, PMID 27053235, PMID 27208317, PMID 27208344, PMID 27465220, PMID 28198767, PMID 29563196, PMID 31212080, PMID 33718234, PMID 37335960, PMID 37706580, PMID 39348419, PMID 39624016, PMID 39949947, PMID 40443407, PMID 42508748

NIH funding

P30CA016672 (4), P01CA148600 (2), P30CA015704 (2), 2009 (1), P01CA049605 (1), P01CA100265 (1), P30CA033572 (1), R01CA061508 (1), R01CA211044 (1), U01AI138909 (1), U10CA031946 (1), U10CA180821 (1), UC4DK117009-01 (1)